Gel4Med-preview

Gelformed

Gel4Med

Private

MassachusettsHealthcare & Life Scienceshttps://www.gelformed.com/

Last Round

Grant

Jul 14, 2025

Total Funding Raised

$2.45M

Momentum Score

25 /100

Company Overview

Gel4Med is a biotechnology company that develops bio-inspired medical solutions for wound care and surgical reconstruction.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Advanced Materials, Defense Tech

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

regenerative medicineadvanced wound caresynthetic biomaterialspeptide hydrogeltissue engineeringsynthetic skin substituteself-assembling peptidessurgical wound matrixextracellular matrix mimicantibacterial biomaterialsmedical devicehydrogel dressingpeptide engineeringFDA 510(k) clearance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Gel4Med Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Gel4Med Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Jul 14, 2025
Grant	May 16, 2025
Grant	May 1, 2024
Grant	Oct 5, 2023
Grant	Sep 3, 2019
Seed	Apr 13, 2017

View all Funding Rounds

Key People

Founding team and executive leadership

Manav Mehta

Chief Executive Officer

Executive Team

Gel4Med Investors

Notable investors and investment history

Investor	Rounds
NIH RADx	Grant
MassVentures	Grant
Massachusetts Life Sciences Center	Grant
Breakout Ventures	Seed
U.S. Department of War	Grant
Congressionally Directed Medical Research Programs	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 20, 2026
Monthly visitors grew 526% MoM.
Jan 5, 2026
Monthly visitors grew 369% MoM.

View all signals

Gel4Med Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Gel4Med Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Gel4Med's valuation, stock price, and market status.

Firmographic Details

HeadquartersMassachusetts

Employee Range19

Year Founded2015

Last FundingJul 14, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.